Inflammatory Markers in Cancer Immunotherapy

1. Multhoff G., Molls M., Radons J. Chronic Inflammation in Cancer Development. Front. Immunol. 2011;2:98. doi:10.3389/fimmu.2011.00098. [PMC free article] [PubMed] [CrossRef] [Google Scholar]2. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002;420:860–867. doi:10.1038/nature01322. [PMC free article] [PubMed] [CrossRef] [Google Scholar]3. Hussain S.P., Harris C.C. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer. 2007;121:2373–2380. doi:10.1002/ijc.23173. [PubMed] [CrossRef] [Google Scholar]4. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–899. doi:10.1016/j.cell.2010.01.025. [PMC free article] [PubMed] [CrossRef] [Google Scholar]5. Templeton A.J., McNamara M.G., Šeruga B., Vera-Badillo F.E., Aneja P., Ocaña A., Leibowitz-Amit R., Sonpavde G., Knox J.J., Tran B., et al. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. J. Natl. Cancer Inst. 20...